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Insulin-induced changes in protein kinase C were examined in cytosol and membrane fractions of rat adipocytes enzymatically after Mono Q column 
chromato~aphy and by ~munoblotting. During a 5-20 min period of insulin treatment, cytosolic protein kinase C decreased by approximately 
50%, whereas membrane protein kinase C increased nearly a-fold. These findings suggest hat insulin stimulates the translocation of protein kinase 
C in rat adipocytes. 
Insulin; Protein kinase C 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Protein kinase C (PI(C) plays an important role in 
transmembrane signalling in various cell types [l-3]. 
PKC is activated by membr~e-associated iacylgly- 
cerol (DAG), which causes PKC to translocate from 
cytosol to membranes, and this translocation serves as 
important evidence for activation of the enzyme [l-4]. 
Insulin increases DAG production by stimulating the 
synthesis of phosphatidic acid (PA) de novo [5-g], and 
the hydrolysis of phosphatidylcholine [9,10] and a 
glycan derivative of phosphatidylinositol [111. Thus, it 
might be expected that the DAG-PKC signalling is im- 
portant during insulin action, and studies of PKC in 
BC3H-1 myocytes [12] and rat diaphragm [13] are in 
accord with this possibility. However, in rat adipo- 
cytes, a model tissue for studies of insulin action, in- 
sulin did not alter the subcellular distribution of PKC 
enzyme activity in one study [14], whereas, in two other 
studies, insulin provoked: (i) increases in cytosolic 
PKC, as judged from phorbol ester binding f15,16]; 
and (ii) increases in PKC enzyme activity of cytosol and 
membrane fractions [16]. Because of these differences 
and the importance attached to the translocation 
response, we re-examined the effects of insulin on 
subcellular distribution of PKC in rat adipocytes. 
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Abbreviutions: PKC, protein kinase C; DAG, diacylglycerol; TPA, 
12-O-tetradecanoyl phorbol-13-acetate; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis; PMSF, phenylmethyl- 
sulfonyl fluoride; DMSO, dimethylsulfoxide; BSA, bovine serum 
albumin 
Phosphatidylserine, diolein, histone (type III-S), 
phenylmethylsulfonyl fluoride (PMSF), leupeptin, 12-O 
tetradecanoyl phorbol-l3-acetate (TPA) and bovine serum albumin 
(BSA) were purchased from Sigma. We purchased ~Y-~‘P]ATP from 
ICN, collagenase from Worthington, and porcine zinc insulin 
(25.7 IU/mg) from Elanco Products. PKC antiserum, raised to syn- 
thetic peptides pecific to rat brain type II PKC (see [17]), was provid- 
ed by Bryan L. Roth and John P. Mehegan, Naval Medical Research 
Institute, Bethesda, MD. Type II PKC is the major isozyme in rat 
adipocytes, as determined by hydroxyapatite column 
chromatography (unpublished observations). 
Epididymal fat pads were obtained from fed male Holtzman rats 
(150-200 g). Free adipocytes were obtained by collagenase digestion 
[IS] of fat pads in Krebs-Ringer-phosphate buffer (KRP) (pH 7.4) 
containing 3% BSA and 2.5 mM glucose. Adipocytes were incubated 
for 30 min at 37°C in glucose-free KRP containing 1% BSA. 
(Glucose-free KRP was used to duplicate conditions generally 
employed in studies of glucose transport, and we routinely observed 
3-S-fold increases in 2-deoxy-[3H]glucose uptake after 15-30 min in- 
sulin treatment. Adipocytes remain fully responsive for 6 h in this 
medium.) Insulin in buffer, TPA in DMSO (0.005~0), or vehicle 
(controls) were then added in a retrograde sequence over the course 
of a 20-min (unless indicated otherwise) period, which was constant 
for all samples. 
Reactions were terminated by addition of 10 ml ice-cold buffer I 
(20 mM Tris-HCl, pH 7.5, 0.25 M sucrose, 1.2 mM EGTA, 0.1 mM 
PMSF, 20 &g/ml leupeptin, 20 mM 2-mercaptoethanol). The 
adipocytes were washed twice and homogenized in buffer I. 
Homogenates were centrifuged at loo0 x g for 2 min, and floating 
fatty materials were removed. Resultant homogenates were centrifug- 
ed at 100000 x g for 60 min to obtain cytosol and pellets. Pellets were 
homogenized in buffer I containing 1% Triton X-100 and centrifuged 
at 100000 x g for 60 min to obtain the solubilized membrane frac- 
tions. Equal amounts of the cytosol or solubilized membrane frac- 
tions from each treatment group, approximately 2 and 0.6 mg 
protein, respectively, were applied to a Mono Q column (0.5 x 5 cm, 
Pharmacia HR 5/S) in a Pharmacia fast protein liquid 
chromatography system equilibrated with buffer II (20 mM Tris- 
HCl, pH 7.5, containing 0.5 mM EGTA, 0.5 mM EDTA, and 
10 mM 2-mercaptoethanol). PKC was eluted with a 20 ml linear gra- 
dient of NaCl (O-O.7 M) in buffer II at a flow rate of 1 ml/min. Frac- 
tions of 1 ml were collected. PKC was assayed by measuring the 
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phosphorylation of histone [19]. The reaction mixture (250 pl, total 
volume) contained 20 mM Tris-HCl, pH 7.5, 5 mM magnesium 
acetate, 0.02% histone, 1OpM [y-3*P]ATP (12 x lo4 cpm/nmol), 
10 pg phosphatidyiserine, 0.1 pg dioiein, 0.5 mM CaC12, and 100 pl 
column fraction. After incubation for 5 min at 3O”C, the reaction 
was stopped with 25% trichloroacetic acid. Acid-precipitable 
materials were collected on membrane filters and counted for 
radioactivity. Basal activity was measured in the presence of 0.5 mM 
EGTA instead of Ca*+, phosphatidylserine and diolein, and was sub- 
tracted from the total protein kinase activity to determine PKC ac- 
tivity. 
the enzyme, or bound lipids or other ligands which may 
influence binding of PKC to the Mono Q column. In 
experiments described below, ‘PKC enzyme activity’ 
was determined by summing the phospholipid/Ca2+- 
dependent enzyme activity found in all column frac- 
tions (i.e. ‘total elutable PKC activity’). 
PKC was also analyzed by immunoblotting (see 1201). Equal 
amounts of cytosol or membrane fractions (5-15 gg of protein) were 
subjected to SDS-PAGE, transferred quantitatively (as per silver 
stain) to nitrocellulose membranes, incubated for 1 h with 3% gelatin 
in Tris-buffered saline (TBS) (20 mM Tris-HCI, pH 7.5, containing 
500 mM NaCi), washed with TBS containing 0.05% Tween (TTBS), 
incubated for 2 h with antiserum to PKC, washed with TTBS, and in- 
cubated for 1 h with goat anti-rabbit y-globutin antibody coupled 
either to horseradish peroxidase or alkaline phosphatase. Im- 
munoreactive proteins were visualized by staining with 
4-chloro-l-naphthol and Hz02 [20], or 0-dianisidine tetrazotized and 
P-naphthyl acid phosphate [21]. In preliminary experiments, we 
documented that staining intensity was directly proportional to the 
PKC content of the sampte subjected to the entire procedure, in- 
cluding SDS-PAGE, transfer and immunoblotting. Protein was 
determined by the method of Bradford [22]. 
Cytosolic PKC enzyme activity decreased rapidly and 
progressively by 53% and 63% over a 20-min period 
upon stimulation of adipocytes with either insulin 
(10 nM) or TPA (100 nM), respectively (fig.2). In- 
creases in membrane PKC enzyme activity were evident 
at 5-20 min of insulin treatment, but the timing of the 
peak was variable. Nevertheless, increases were observ- 
ed in each of the 4 experiments of fig.2, and, if all 
insulin-stimulated membrane values at 5, 10 and 
20 min are considered collectively, the overall mean f 
SE percent increase was 92 zf: 31 (n = 12; P < 0.02; 
paired t-test). With TPA treatment, increases in mem- 
brane enzyme activity were observed less consistently. 
GIynn et al. [I41 also did not observe consistent in- 
creases in membrane PKC activity during TPA treat- 
ment of rat adipocytes. 
3. RESULTS 
During Mono Q column chromatography of cytosol 
and membrane fractions from rat adipocytes, 
phospholipid/Ca2+-dependent protein kinase activity 
eluted as shown in fig.1. This elution profile is similar 
to that of rat brain PKC [23]. Addition of either Ca2+ 
or phospholipids alone to these assays did not stimulate 
histone phosphorylation significantly above that 
observed with EGTA. Thus, simple Ca2+-dependent, 
protein kinase activity was not found in PKC- 
containing fractions. Further CAMP-dependent protein 
kinase activity eluted prior to PKC (data not shown). 
It may be noted that there were slight differences bet- 
ween PKC elution profiles of cytosol and membrane 
fractions, and from experiment to experiment. This 
may reflect differences in the phosphorylation state of 
Fig.3 shows an immunoblot of cytosol and mem- 
brane fractions from control, and insulin- or TPA- 
treated tissues. As in the BCSH-I myocyte [20], only 
one major band of immunoreactivity was found, and 
this co-migrated on SDS-PAGE and blotted identically 
with highly purified 80 kDa rat brain PKC. Cytosol im- 
munoreactivity decreased, whereas membrane im- 
munoreactivity increased during treatment with either 
10 nM insulin or 100 nM TPA. In 4 similar ex- 
periments in which blots were evaluated by den- 
sitometry scanning 1201, the decrease in cytosolic 
immunoreactivity at 20 min of insulin treatment was 47 
+ 7% (mean * SE; P c 0.01, paired t-test). Com- 
parable immunoblot results were obtained with another 
antiserum (see [20]), and which recognizes types I, II 
and III PKC. 
We also evaluated changes in PKC with more pro- 
longed insulin treatment (fig.4). After 60 min of insulin 
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Fig. 1. Elution patterns of protein kinase activity of cytosol and membrane fractions from rat adipocytes during purification by Mono Q column 
chromatography. Cytosol and membrane fractions were applied to the column, and fractions were assayed for protein kinase activity, in the 
presence of phosphatidylserine (40 agiml), diolein (0.4 pg/mI) and 0.5 mM CaClz (+---+I, 0.5 mM EGTA (H), 0.5 mM CaClz (D---U), or 
phosphatidytserine (40 #g/ml) (o - - - 0). 
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Fig.2. Time course of effects of insulin (10 nM) (left) and TPA (100 nM) (right) on cytosolic and membrane-associated protein kinase C. Total 
elutable protein kinase C activity was determined after purification of the enzyme by chromatography on the Mono Q column (see figs 1 and 
4). Mean f SE results of 4 insulin and 3 TPA experiments are shown, expressed as % of control activity. * P < 0.05 (paired t-test). 
treatment, there was a profound loss in cytosolic PKC 
enzyme activity. Membrane PKC enzyme activity re- 
mained elevated, but, as is evident, total PKC enzyme 
activity decreased. Similarly, changes in cytosol and 
membrane PKC were observed at 30 and 120 min of in- 
sulin treatment (data not shown). 
4. DISCUSSION 
In this study, we found that insulin provoked rapid 
changes in rat adipocyte PKC, suggestive of transloca- 
tion of the enzyme from the cytosol to the membrane 
fraction. Using chromatography on Mono Q columns 
to purify PKC, we observed decreases in cytosol en- 
zyme activity, and increases in membrane-associated 
enzyme activity, during 5-20 min of insulin treatment. 
Similar changes in immunoreactive PKC were also 
observed with insulin treatment. It therefore seems like- 
ly that our enzyme assays primarily reflected changes in 
-1QnM llIsukl- -tiXhtM TPA - 
Fig.3. Immunoblot analysis of insulin (10 nM)- and TPA (100 nM)- 
induced changes in protein kinase C content of cytosol (5 pg protein) 
and membrane (10 pg protein) fractions of rat adipocytes. Times of 
insulin or TPA treatment are depicted in the figure, with the control 
(0) shown in the center. Similar results were observed in at least 3 
other experiments for each agonist. 
enzyme content, and, moreover, by two independent 
methods, we were able to observe evidence of 
subcellular redistribution of PKC during insulin treat- 
ment of adipocytes. Interestingly, similar evidence for 
PKC translocation was observed during insulin treat- 
ment of BC3H-1 myocytes [20]. 
Insulin-induced changes in adipocyte cytosolic PKC 
were comparable to those of TPA, which binds to and 
activates PKC [ 1,3,4] and provokes the translocation of 
PKC from the cytosol to the plasma membrane [1,3,4]. 
Our findings with TPA are similar to those observed by 
others in rat adipocytes [14] and other tissues, although 
CYTOSOL MEMBRANE 
Fig.4. Effects of more prolonged insulin treatment on rat adipocyte 
protein kinase C enzyme activity. Adipocytes were incubated for 
60 min with or without insulin (10 nM). Protein kinase C enzyme 
activity was determined after chromatography of cytosol (left) and 
membrane (right) fractions on the Mono Q column (see figs 2 and 3). 
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proteolytic conversion of PKC to M-kinase and other 
products [25,26] may have limited the accumulation of 
the holoenzyme in the membrane fraction. However, 
during insulin treatment, this proteolysis may have 
been less intense than with TPA, as more prominent in- 
creases in membrane PKC were observed. 
The subcellular redistribution and apparent 
translocation of PKC observed presently provides fur- 
ther evidence (see [ 15,161) that insulin activates PKC in 
rat adipocytes. Nevertheless, our findings differ from 
those of previous studies, probably because of the 
following. Most importantly, we purified PKC by 
chromatography on Mono Q columns, and this 
removes DAG, and possibly other endogenous ac- 
tivators and inhibitors, more effectively than DEAE- 
cellulose columns (submitted for publication). We also 
employed optimal concentrations of diolein and our en- 
zyme assays probably primarily reflected changes in 
content, rather than enzymatic activity, of PKC. In 
support of this, we observed similar changes in im- 
munoreactive PKC. In previous studies [ 14,161 of PKC 
enzyme activity, cytosols were used without purifica- 
tion, or after chromatography on DEAE-cellulose col- 
umns. Since these cytosols contain substantial amounts 
of lipids (see above), including DAG, increases in en- 
zyme activity may have obscured decreases in enzyme 
content. In studies using PKC binding assays [ 15,161, 
increases in cytosol activity may have reflected the 
translocation of PKC to the membrane fraction, 
followed by proteolytic cleavage, and release to the 
cytosol of regulatory fragments, which may bind label- 
ed phorbol esters more effectively than the 
holoenzyme. 
In summary, using two independent methods, we 
have found that insulin provokes rapid changes in 
cytosol and membrane PKC in rat adipocytes. Our fin- 
dings suggest that PKC is translocated from the cytosol 
to the membrane fraction during insulin action, and 
this suggests that insulin activates PKC in rat 
adipocytes. 
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